IN2013CH03939A - - Google Patents

Download PDF

Info

Publication number
IN2013CH03939A
IN2013CH03939A IN3939CH2013A IN2013CH03939A IN 2013CH03939 A IN2013CH03939 A IN 2013CH03939A IN 3939CH2013 A IN3939CH2013 A IN 3939CH2013A IN 2013CH03939 A IN2013CH03939 A IN 2013CH03939A
Authority
IN
India
Prior art keywords
relates
strokes
prevention
preparation
acid addition
Prior art date
Application number
Inventor
Velayudhan Nair Subha
Babu Bollu Ravindra
Kumar Barik Prasanth
Sunil Kumar Indukuri Venkata
Ramanjaneyulu Gorantla Seeta
Chava Satyanarayana
Original Assignee
Laurus Labs Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laurus Labs Pvt Ltd filed Critical Laurus Labs Pvt Ltd
Priority to PCT/IN2014/000575 priority Critical patent/WO2015033353A2/en
Priority to IN3939CH2013 priority patent/IN2013CH03939A/en
Publication of IN2013CH03939A publication Critical patent/IN2013CH03939A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to novel acid addition salts of dabigatran etexilate, process for the preparation and pharmaceutical compositions containing the same. Further, the invention relates to uses of said compositions for post operative prophylaxis of deep vein thrombosis and the prevention of strokes.
IN3939CH2013 2013-09-03 2014-09-03 IN2013CH03939A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2014/000575 WO2015033353A2 (en) 2013-09-03 2014-09-03 Novel acid addition salts of dabigatran etexilate and process for the preparation thereof
IN3939CH2013 IN2013CH03939A (en) 2013-09-03 2014-09-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3939CH2013 IN2013CH03939A (en) 2013-09-03 2014-09-03

Publications (1)

Publication Number Publication Date
IN2013CH03939A true IN2013CH03939A (en) 2015-09-11

Family

ID=52629059

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3939CH2013 IN2013CH03939A (en) 2013-09-03 2014-09-03

Country Status (2)

Country Link
IN (1) IN2013CH03939A (en)
WO (1) WO2015033353A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2300431B1 (en) * 2008-06-16 2016-01-06 Boehringer Ingelheim International GmbH Process for the manufacture of an intermediate in the synthesis of dabigatran
HUE026408T2 (en) * 2010-09-27 2016-06-28 Ratiopharm Gmbh Dabigatran etexilate bismesylate salt, solid state forms and process for preparation thereof
HUP1100244A2 (en) * 2011-05-11 2012-11-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Pharmaceutical intermediates and process for their production
WO2013124749A1 (en) * 2012-02-20 2013-08-29 Alembic Pharmaceuticals Limited Novel polymorph of dabigatran etexilate

Also Published As

Publication number Publication date
WO2015033353A3 (en) 2015-06-04
WO2015033353A2 (en) 2015-03-12

Similar Documents

Publication Publication Date Title
PH12017500408A1 (en) Heteroaryl compunds as btk inhibitors and uses thereof
MD4650B1 (en) Quinazoline derivatives used to treat HIV
MD4800B1 (en) Aminopyrimidinyl compounds as JAK inhibitors
AU2015207757A8 (en) N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2
MX2017008518A (en) Isoquinoline compounds for the treatment of hiv.
PH12018500446A1 (en) Pyridinone dicarboxamide for use as bromodomain inhibitors
UA113470C2 (en) PIRIMIDINE AND PORIDINE COMPOUNDS AND THEIR APPLICATIONS
MX2020001756A (en) Benzoquinolone inhibitors of vmat2.
MX2017014035A (en) Solid forms.
MY186547A (en) 4?-fluoro-2?-methyl substituted nucleoside derivatives
EA201692548A1 (en) MINERAL AMINO ACID COMPLEXES OF ACTIVE SUBSTANCES
MX2016005760A (en) Gsk-3 inhibitors.
EA201500931A1 (en) PYRIDIN-4-ILA DERIVATIVES
MX2017005578A (en) Methods of administering amantadine compositions.
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
IN2014MU00675A (en)
MX366829B (en) Itraconazole compositions and dosage forms, and methods of using the same.
MX365315B (en) Substituted pyridine derivatives useful as c-fms kinase inhibitors.
PH12016502322B1 (en) Compounds and methods for preventing or treating malaria
EA201591449A1 (en) METHODS OF OBTAINING TREATMENT COMPOSITIONS
IN2013MU01290A (en)
PH12015502703A1 (en) Pharmaceutical compositions
GB2557753A (en) Substituted aminoalkylazoles as malarial aspartic protease inhibitors
IN2013CH03939A (en)
IN2013CH04314A (en)